Steris (STE) Capital Expenditures Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -18.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.22% |
| Dec 31, 2025 | 10.65% |
| Sep 30, 2025 | -15.11% |
| Jun 30, 2025 | -13.41% |
| Mar 31, 2025 | -22.52% |
| Dec 31, 2024 | -25.00% |
| Sep 30, 2024 | 22.34% |
| Jun 30, 2024 | 62.31% |
| Mar 31, 2024 | 28.06% |
| Dec 31, 2023 | 29.53% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | -42.55% |
| Mar 31, 2023 | -2.22% |
| Dec 31, 2022 | 13.19% |
| Sep 30, 2022 | 7.53% |
| Jun 30, 2022 | 105.57% |
| Mar 31, 2022 | -2.26% |
| Dec 31, 2021 | 50.92% |
| Sep 30, 2021 | 75.40% |
| Jun 30, 2021 | -15.65% |
| Mar 31, 2021 | 22.83% |
| Dec 31, 2020 | -3.12% |
| Sep 30, 2020 | -9.28% |
| Jun 30, 2020 | 34.28% |
| Mar 31, 2020 | -20.41% |
| Dec 31, 2019 | 9.46% |
| Sep 30, 2019 | 38.91% |
| Jun 30, 2019 | 79.59% |